Intrinsiqq
Pulse Biosciences, Inc. logo

Pulse Biosciences, Inc.

PLSE

⊜ Compare

We are a novel ablation company committed to health innovation using our patented Nano-pulse Stimulation ( NPS ) technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to nonthermally clear or kill targeted cells. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation ( nsPFA …

Valuation & Multiples

Based on TTM earnings · Diluted shares

Market Cap$4.07B
EPS-$1.16
P/E-49.24
P/FCF-66.29
EV/EBITDA-47.87
FCF Yield–
Div. Yield–
Net Debt/FCF1.5x
Pulse Biosciences, Inc. intrinsic value
52-Week Range
$12.66$57.06

Profitability & Returns

Revenue (TTM)

$1M

Net Income (TTM)

-$80M

▼ -35.8% YoY

Op. Margin

-7007.76%

ROIC

-71.21%

▼ -7.2pp YoY

Cash Flow & Balance Sheet

FCF (TTM)

-$61M

▼ -49.3% YoY

Op. Cash Flow (TTM)

-$61M

▼ -48.9% YoY

Net Debt

-$95M

Net Cash Position

Cash & Equiv.

$102M

Continue Research

Peers

Surgical & Medical Instruments & Apparatus · Pick stocks to compare with PLSE

CompareIntrinsic value
PETVPetvivo Holdings Inc
$0.60+1.69%26
VTAKCatheter Precision, Inc.
$0.56-5.08%40
SINTSintx Technologies Inc.
$1.66-3.49%10
HRGNHarvard Apparatus Regenerative Technology Inc.
$2.30+0.00%10
EMEDElectromedical Technologies Inc.
$0.00+0.00%26
EBRCZEBR Systems, Inc.
$0.08+0.00%0
CODXCo-Diagnostics Inc.
$0.36-5.00%10
ICUSeastar Medical Holding Corporation
$2.04+2.00%20

Held by ETFs

PLSE is in 20 US ETFs. The largest of them, with PLSE's weight in each:

Pulse Biosciences (PLSE) in four numbers

Fair value (revenue)
$0.04
Price $57.06 is 162577% above it.
Intrinsic Value
Quality score
40/100
Best check: revenue growth, 14.1%. Weakest: return on capital, -71.2%.
Quality
Dividend
None
No dividend in the SEC filings we hold.
Dividends
P/E
-49.24
Negative: a loss over the last twelve months. Price to free cash flow -66.29.
Financials

Questions about Pulse Biosciences

Is Pulse Biosciences (PLSE) overvalued?

At $57.06, Pulse Biosciences' price is 162577% above the $0.04 a share fair value that Intrinsiqq's calculator gets from its revenue. The growth behind that figure is yours to set on the Intrinsic Value tab. See how to tell if a stock is overvalued.

What is Pulse Biosciences' fair value?

Intrinsiqq's calculator puts Pulse Biosciences' fair value at $0.04 a share. It grows revenue per share 0% a year for 5 years, applies an exit P/S of 3.4, and works back at a 10% yearly return. A 25% margin of safety gives a buy-below price of $0.03. Every input can be changed on the Intrinsic Value tab.

Is Pulse Biosciences a high-quality business?

Pulse Biosciences scores 40 out of 100 on Intrinsiqq's quality score, which makes it a mixed business on these measures. The score blends 6 checks computed from SEC filings. Its best check is revenue growth at 14.1%, and its weakest is return on capital at -71.2%. The Quality tab shows every check against its target.

Does Pulse Biosciences (PLSE) pay a dividend?

No. Pulse Biosciences (PLSE) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.

Source: 10-Q filed 31 Jul 2026 (period ending 30 Jun 2026), SEC. Price: last close 4 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.

Spot a number that looks wrong? Check it in PLSE's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing PLSE

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.